Electrochemical Formation of Tricyclic Indolizidine and Quinolizidine Derivatives
FULL PAPER
117.8 (d, C-1), 153.3 (s, C-2) ppm. MS (GC-MS*): m/z (%) ϭ 221 H), 5.49 (s, 1 H, 1-H) ppm. 13C NMR (75.5 MHz, CDCl3): δ ϭ
(6) [Mϩ], 220 (11) [Mϩ Ϫ H], 206 (3), 122 (15) [Mϩ Ϫ C6H11O], 23.1 (q, CH3), 26.5 (t), 30.2 (t), 34.0 (t), 37.0 (t), 48.4 (t, C-4), 51.2
110 (23) [Mϩ Ϫ C7H11O], 96 (100) [Mϩ Ϫ C8H13O], 94 (23), 81 (d, C-6a), 58.4 (t, C-6), 71.5 (d, C-9b), 90.5 (s, C-9a), 119.3 (d, C-
(11), 67 (8), 55 (12), 41 (20), 39 (18). C14H23NO (221.34): calcd. C 1), 134.3 (s, C-2) ppm. MS (GC-MS*): m/z (%) ϭ 194 (9) [Mϩ
ϩ
75.97, H 10.47, N 6.33; found C 75.73, H 10.64, N 6.34.
H], 192 (10) [Mϩ Ϫ H], 178 (5), 109 (100) [Mϩ Ϫ C5H8O], 96 (20)
[Mϩ Ϫ C6H9O], 94 (19), 81 (21), 67 (6), 55 (6), 41 (18), 39 (20).
C12H19NO (193.29): calcd. C 74.57, H 9.91, N 7.25; found C 74.38,
H 10.04, N 7.24.
rac-(7aR,11aS,11bS)-2-Methyl-3,4,6,7,7a,8,9,10,11a,11b-deca-
hydro[11H]-cyclohexa[a]quinolizin-11a-ol (2a):[41] M.p. 90 °C. IR
(KBr): ν˜ ϭ 3412 (s), 3036 (w), 2956 (s), 2928 (s), 2908 (s), 2859 (s),
2816 (s, NCϪH), 2772 (m, NCϪH), 1638 (w), 1618 (w), 1465 (m),
rac-(6aR,9aS,9bS)-2-Methyl-3,4,6,6a,7,8,9a,9b-octahydro-9H-
1447 (m), 1398 (w), 1380 (w), 1349 (m), 1317 (s), 1288 (m), 1268 cyclopenta[a]indolizin-9a-ol (3a): M.p. 85 °C. IR (KBr): ν˜ ϭ 3470
(m), 1229 (w), 1198 (m), 1171 (w), 1130 (s), 1112 (m), 1047 (s), (m), 3407 (m), 3356 (s), 3232 (s), 3042 (w), 2937 (s), 2921 (s), 2905
1011 (m), 952 (w), 923 (w), 880 (m), 859 (m), 809 (w), 762 (w) (s), 2886 (s), 2869 (s), 2852 (s), 2794 (m, NCϪH), 2776 (s, NCϪH),
cmϪ1
.
1H NMR (300.1 MHz, CDCl3): δ ϭ 1.20 Ϫ1.50 (m, 5 H), 2724 (m, NCϪH), 1638 (w), 1618 (w), 1467 (m), 1445 (m), 1395
1.55Ϫ1.82 (m, 5 H), 1.71 (s, 3 H, CH3), 2.02Ϫ2.08 (m, 1 H),
(m), 1372 (m), 1329 (m), 1311 (s), 1290 (s), 1262 (m), 1244 (m),
2.23Ϫ2.40 (m, 2 H), 2.41Ϫ2.52 (m, 2 H), 2.60 (mc, 1 H), 2.78 (mc, 1217 (m), 1196 (m), 1174 (m), 1149 (s), 1128 (m), 1079 (s), 1064
1
1 H), 3.05 (s, 1 H, 11b-H), 3.63 (s, 1 H, OH), 5.39 (s, 1 H, 1-H) (s), 1044 (m), 911 (m), 875 (s), 836 (m), 694 (m) cmϪ1. H NMR
ppm. 13C NMR (75.5 MHz, CDCl3): δ ϭ 22.7 (t, C-10), 23.5 (q, (300.1 MHz, CDCl3): δ ϭ 1.30Ϫ1.40 (m, 1 H), 1.50Ϫ1.70 (m, 2
CH3), 26.3, 27.4, 28.4 (3 t, C-7, C-8, C-9), 30.4 (t, C-3), 34.2 (t, C-
H), 1.72 (s, 3 H, CH3), 1.73Ϫ2.00 (m, 5 H), 2.25Ϫ2.42 (m, 4 H, 4-
11), 42.7 (d, C-7a), 51.5, 52.3 (2 t, C-4, C-6), 60.4 (d, C-11b), 71.2 H, 6-HA, 6a-H), 2.75 (s, 1 H, OH), 3.00Ϫ3.10 (m, 1 H, 9b-H), 3.26
(s, C-11a), 117.7 (d, C-1), 135.8 (s, C-2) ppm. MS (GC-MS*): m/z
(dd, 3J ϭ 8.6, 2J ϭ 8.6 Hz, 1 H, 6-HB), 5.49 (s, 1 H, 1-H) ppm.
13C NMR (75.5 MHz, CDCl3): δ ϭ 23.0 (q, CH3), 25.5 (t), 30.1
(%) ϭ 221 (6) [Mϩ], 220 (11) [Mϩ Ϫ H], 206 (3), 122 (16) [Mϩ
Ϫ
C6H11O], 110 (23) [Mϩ Ϫ C7H11O], 96 (100) [Mϩ Ϫ C8H13O], 94 (t), 30.9 (t), 36.2 (t), 48.5 (t, C-4), 51.6 (d, C-6a), 59.6 (t, C-6), 70.1
(25), 81 (11), 67 (10), 55 (13), 41 (20), 39 (21). C14H23NO (221.34): (d, C-9b), 89.8 (s, C-9a), 118.1 (d, C-1), 135.9 (s, C-2) ppm. MS
calcd. C 75.97, H 10.47, N 6.33; found C 76.02, H 10.57, N 6.45.
(GC-MS*): m/z (%) ϭ 192 (6) [Mϩ Ϫ H], 178 (4), 150 (3), 109
(100) [Mϩ Ϫ C5H8O], 96 (30) [Mϩ Ϫ C6H9O], 94 (25), 81 (31), 67
(10), 55 (10), 41 (24), 39 (25). C12H19NO (193.29): calcd. C 74.57,
H 9.91, N 7.25; found C 74.50, H 9.98, N 7.59.
rac-(7aS,11aR,11bS)-2-Methyl-3,4,6,7,7a,8,9,10,11a,11b-deca-
hydro[11H]-cyclohexa[a]quinolizin-11a-ol (2b):[41] M.p. 146 °C. IR
(KBr): ν˜ ϭ 3413 (s), 3029 (w), 2932 (s), 2914 (s), 2858 (s), 2814 (s,
NCϪH), 2742 (w, NϪCH), 1638 (m), 1618 (m), 1464 (m), 1439 Electrolysis of N-(1,4-Dioxaspiro[4.5]dec-6-ylmethyl)-4-methylpyrid-
(m), 1397 (w), 1350 (m), 1321 (m), 1271 (m), 1207 (s), 1186 (m), inium Trifluoromethanesulfonate (30): The pyridinium salt 30
1142 (m), 1130 (m), 1113 (s), 1085 (w), 1068 (w), 1043 (m), 1014
(m), 992 (m), 962 (w), 891 (s), 865 (w) cmϪ1. 1H NMR (300.1 MHz, sulfuric acid (1 , 30 mL) and electrolysed according to the General
CDCl3): δ ϭ 1.26Ϫ1.60 (m, 9 H), 1.69 (s, 3 H, CH3), 1.70Ϫ1.85 Procedure until 5775 C (2.6-fold excess) had been transferred. The
(m, 2 H), 1.90Ϫ2.05 (m, 2 H), 2.12Ϫ2.38 (m, 4 H), 2.75Ϫ2.90 (m, crude product was analysed by GC (4a/4b ϭ 1.7:1.0) and subjected
2 H), 5.49 (s, 1 H, 1-H) ppm. 13C NMR (75.5 MHz, CDCl3): δ ϭ
to short path flash chromatography (diethyl ether/triethylamine,
(2.41 g, 5.69 mmol based on pure salt 32) was dissolved in aqueous
20.3, 21.4, 23.0 (q, CH3), 26.8, 26.9, 27.8, 30.5 (6 t, C-3, C-7, C-8 10:1) to give a mixture (771 mg, 3.72 mmol, 65%) of the two iso-
to C-11), 42.8 (d, C-7a), 52.5, 56.1 (2 t, C-4, C-6), 71.4 (d, C-11b), mers. The diastereomers were separated over a longer column (di-
72.2 (s, C-11a), 119.1 (d, C-1), 133.4 (s, C-2) ppm. MS (GC-MS*):
m/z (%) ϭ 221 (6) [Mϩ], 220 (15) [Mϩ Ϫ H], 206 (3), 122 (21) [Mϩ
Ϫ C6H11O], 110 (28) [Mϩ Ϫ C7H11O], 96 (100) [Mϩ Ϫ C8H13O],
94 (26), 81 (10), 80 (11), 67 (8), 55 (12), 41 (21), 39 (20). C14H23NO
(221.34): calcd. C 75.97, H 10.47, N 6.33; found C 75.69, H 10.74,
N 6.55.
ethyl ether/triethylamine, 10:1): 4a (Rf ϭ 0.30, white crystalline
solid), 4b (Rf ϭ 0.13, white amorphous solid).
rac-(6aR,10aS,10bS)-2-Methyl-3,4,6,6a,7,8,9,10,10a,10b-deca-
hydrocyclohexa[a]indolizin-10a-ol (4a):[42] M.p. 119 °C. IR (KBr):
ν˜ ϭ 3416 (m), 3052 (s), 2971 (s), 2928 (s), 2853 (s), 2825 (m,
NCϪH), 1638 (w), 1618 (w), 1492 (m), 1441 (s), 1377 (w), 1345
(m), 1306 (s), 1262 (m), 1224 (m), 1212 (m), 1200 (w), 1160 (s),
Electrolysis of N-(1,4-Dioxaspiro[4.4]non-6-ylmethyl)-4-methylpyri-
dinium Trifluoromethanesulfonate (29): The pyridinium salt 29 1141 (s), 1078 (m), 1047 (m), 1032 (m), 1003 (m), 984 (m), 963 (w),
1
(2.55 g, 5.77 mmol based on pure salt 30) was dissolved in aqueous 842 (m), 801 (m), 717 (m) cmϪ1. H NMR (300.1 MHz, CDCl3):
sulfuric acid (1 , 30 mL) and electrolysed according to the General
Procedure until 5160 C (2.3-fold excess) had been transferred. The 2.10Ϫ2.25 (m, 1 H, 6a-H), 2.39 (dd, J ϭ 9.3, J ϭ 3.3 Hz, 1 H,,
δ ϭ 1.18Ϫ1.43 (m, 3 H), 1.50Ϫ2.00 (m, 7 H), 1.76 (s, 3 H, CH3),
2
3
crude product was analysed by GC (3a/3b ϭ 1.0:2.8) and subjected
to flash chromatography (diethyl ether/triethylamine, 10:1) to give
two fractions of isomeric products 3b (Rf ϭ 0.73, 659 mg, slowly
crystallising white solid) and 3a (Rf ϭ 0.40, 267 mg, white crystal-
line solid). Combined yield: 926 mg (4.79 mmol, 83%).
6-HA), 2.64Ϫ2.73 (mc, 1 H, 4-HA), 2.88Ϫ2.95 (mc, 1 H, 4-HB), 3.15
(dd, 2J ϭ 9.3, 3J ϭ 7.2 Hz, 1 H, 6-HB), 3.24 (mc, 1 H, 10b-H), 5.39
(s, 1 H, 1-H) ppm. 13C NMR (75.5 MHz, CDCl3): δ ϭ 22.4 (t),
23.6 (q, CH3), 23.8 (t), 29.4 (t), 30.2 (t), 31.9 (t), 45.0 (d, C-6a),
48.2 (t, C-4), 57.3 (t, C-6), 62.9 (d, C-10b), 78.3 (s, C-10a), 117.5
(d, C-1), 138.0 (s, C-2) ppm. MS (GC-MS*): m/z (%) ϭ 207 (2)
[Mϩ], 206 (5) [Mϩ Ϫ H], 159 (4), 109 (100) [Mϩ Ϫ C6H10O], 96
(20) [Mϩ Ϫ C7H11O], 94 (22), 81 (36), 67 (8), 55 (8), 41 (20), 39
(25). C13H21NO (207.32): calcd. C 75.32, H 10.21, N 6.76; found
C 75.11, H 10.38, N 6.91.
rac-(6aR,9aS,9bR)-2-Methyl-3,4,6,6a,7,8,9a,9b-octahydro-9H-
cyclopenta[a]indolizin-9a-ol (3b): M.p. 35 °C. IR (KBr): ν˜ ϭ 3409
(s), 3322 (s), 2944 (s), 2906 (s), 2862 (m), 2806 (s, NCϪH), 2727
(m, NCϪH), 1666 (w), 1638 (w), 1618 (w), 1446 (m), 1377 (m),
1321 (s), 1281 (s), 1209 (m), 1187 (s), 1132 (m), 1102 (m), 1085 (m),
1041 (m), 1017 (s), 980 (m), 936 (m), 915 (w), 865 (s), 835 (w) cmϪ1
.
rac-(6aR,10aS,10bR)-2-Methyl-3,4,6,6a,7,8,9,10,10a,10b-deca-
1H NMR (300.1 MHz, CDCl3): δ ϭ 1.22Ϫ1.38 (m, 1 H), 1.55Ϫ1.68 hydrocyclohexa[a]indolizin-10a-ol (4b):[42] M.p. 104 °C. IR (KBr):
(m, 4 H), 1.69 (s, 3 H, CH3), 1.80Ϫ1.91 (m, 1 H), 2.05Ϫ2.20 (m, 2 ν˜ ϭ 3412 (m), 3097 (s), 2971 (s), 2925 (s), 2836 (s, NCϪH), 1638
H), 2.22Ϫ2.45 (m, 3 H), 2.50Ϫ2.65 (m, 3 H), 2.95 (mc, 1 H, 9b-
(w), 1618 (w), 1449 (s), 1427 (s), 1374 (m), 1350 (s), 1319 (s), 1282
Eur. J. Org. Chem. 2003, 2919Ϫ2932
2003 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
2929